Blood test triggers early attack on lingering cancer cells
NCT ID NCT04457297
Summary
This study tested whether giving a cancer drug early, based on a sensitive blood test, could prevent colorectal cancer from returning after surgery. It involved 243 patients who had their cancer surgically removed but still had tiny traces of cancer DNA in their blood. Half received the drug (FTD/TPI) and half received a placebo, to see if early treatment improved survival and cleared the cancer DNA.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aichi Cancer Center Hospital
Nagoya, Aichi-ken, 464-8681, Japan
-
Aizawa Hospital
Matsumoto, Nagano, 390-8510, Japan
-
Cancer Institute Hospital Of JFCR
Koto, Tokyo, 135-8550, Japan
-
Chiba Cancer Center
Chiba, Chiba, 260-8717, Japan
-
Gifu University Hospital
Gifu, Gifu, 501-1194, Japan
-
Hiroshima University Hospital
Hiroshima, Hiroshima, 734-8551, Japan
-
Hokkaido University Hospital
Sapporo, Hokkaido, 060-8648, Japan
-
Hospital of the University of Occupational and Environmental Health
Kitakyushu, Fukuoka, 807-8556, Japan
-
Kagawa University Hospital
Kita, Kagawa-ken, 761-0793, Japan
-
Kanagawa Cancer Center
Yokohama, Kanagawa, 241-8515, Japan
-
Kanazawa University Hospital
Kanazawa, Ishikawa-ken, 920-8641, Japan
-
Kansai Medical University Hospital
Hirakata, Osaka, 573-1191, Japan
-
Kumamoto University Hospital
Kumamoto, Kumamoto, 860-8556, Japan
-
Kyorin University Hospital
Mitaka, Tokyo, 181-8611, Japan
-
Kyoto-Katsura Hospital
Kyoto, Kyoto, 615-8256, Japan
-
Kyushu University Hospital
Fukuoka, Fukuoka, 812-8582, Japan
-
National Cancer Center Hospital
Chūō, Tokyo, 104-0045, Japan
-
National Cancer Center Hospital East
Kashiwa, Chiba, 277-8577, Japan
-
National Hospital Organization Kyushu Cancer Center
Fukuoka, Fukuoka, 811-1395, Japan
-
National Hospital Organization Osaka National Hospital
Osaka, Osaka, 540-0006, Japan
-
National Taiwan University Hospital
Taipei, Taiwan, 100229, Taiwan
-
Okayama University Hospital
Okayama, Okayama-ken, 700-8558, Japan
-
Osaka Medical and Pharmaceutical University Hospital
Takatsuki, Osaka, 569-8686, Japan
-
Osaka University Hospital
Suita, Osaka, 565-0871, Japan
-
Saitama Cancer Center
Saitama, Saitama, 362-0806, Japan
-
Sano Hospital
Kobe, Hyōgo, 655-0031, Japan
-
Sapporo Medical University Hospital
Sapporo, Hokkaido, 060-8543, Japan
-
Shikoku Cancer Center
Matsuyama, Ehime, 791-0280, Japan
-
Shimane Prefectural Central Hospital
Izumo, Shimane, 693-8555, Japan
-
Shizuoka Cancer Center
Shizuoka, Shizuoka, 411-8777, Japan
-
St. Marianna University School of Medicine Hospital
Kawasaki, Kanagawa, 216-8511, Japan
-
Tohoku University Hospital
Sendai, Miyagi, 980-8574, Japan
-
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
Bunkyo, Tokyo, 113-8677, Japan
-
Toyama University Hospital
Toyama, Toyama, 930-0194, Japan
-
University Hospital, Kyoto Prefectural Univercity of Medicine
Kyoto, Kyoto, 602-8566, Japan
-
University of Fukui Hospital
Yoshida, Fukui, 910-1193, Japan
-
University of Tsukuba Hospital
Tsukuba, Ibaraki, 305-8576, Japan
-
University of the Ryukyus Hospital
Nakagami, Okinawa, 903-0215, Japan
-
Yokohama City University Medical Center
Yokohama, Kanagawa, 232-0024, Japan
Conditions
Explore the condition pages connected to this study.